Gene therapy for diabetes mellitus:construction and identification of eukaryotic cell expression plasmid in rat proinsulin gene

蒋琳,季旻珺,吴海玮,贾悦,唐伟,刘翠萍,张兆松,刘超

DOI: https://doi.org/10.3321/j.issn:1673-8225.2004.27.049

2004-01-01

Abstract:Aim: To construct eukaryotic cell expression plasmid of rat proinsulin gene pCMV/proinsulin and measure the sequence. Methods: One male SD rat was involved and total RNA was extracted from rat pancreatic and the desired cDNA sequence with full length was obtained by RT-PCR. According to the characteristic of eukaryotic cell expression vector pCMV-Script possessing multiple restriction enzyme sites, EcoR I and Hind III sites was selected by using the modern molecular biology technique and proinsulin gene with the same restriction enzyme sites. Then rat proinsulin gene was orient cloned into expression plasmid pCMV by its sticky end. Results: The proinsulin gene of rat was acquired by RT-PCR and measured with DNA nucleic acid sequence. The positive cloned insert of the recombinant plasmid was screened and identified by PCR and double digestion with the restriction enzymes(EcoR I and Hind III ), and was further sequenced using Sanger-dideoxy-mediated nucleotide chain termination method. The sequence with full length of rat proinsulin gene was consistent with that of references published. Conclusion: The recombinant eukaryotic cell expression plasmid of rat proinsulin gene pCMV/proinsulin has been obtained. This will provide a basis for the further studies of rat proinsulin gene transfected into diabetic rat and non-pancreas islet β cell as gene therapy strategies for diabetics.